Location History:
- Gainsville, FL (US) (2010)
- Gainesville, FL (US) (2006 - 2013)
- Alachua, FL (US) (2018 - 2024)
- San Diego, CA (US) (2021 - 2024)
Company Filing History:
8 out of 2,928 
8 out of 14 
2 out of 8,684 
Years Active: 2006-2024
Title: The Innovative Contributions of Ronald L. Hayes in Neurological Diagnostics
Introduction: Ronald L. Hayes, an accomplished inventor based in Gainesville, FL, has made significant strides in the field of neurological diagnostics through his innovative research and development efforts. With a total of 11 patents, his work largely focuses on identifying and diagnosing brain injuries and other neurological conditions.
Latest Patents: Two of Ronald L. Hayes's most recent inventions are pivotal in advancing medical technology in the diagnosis of brain injuries. The first patent details the development of antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP). These antibodies are crucial for in vitro detection of UCH-L1 and GFAP in individuals suspected of having neurological damage, such as mild traumatic brain injury. The invention includes methods, systems, and kits designed for diagnosing brain injuries effectively, thus presenting significant potential for clinical applications.
Another notable patent involves the identification of micro-RNA, autoantibody, and protein markers for diagnosing neuronal injury. This invention encompasses processes and materials aimed at detecting or assessing the severity of various neurological injuries, including traumatic brain injury and conditions like Alzheimer’s disease and Parkinson’s disease. The biomarkers identified in biological samples such as blood and cerebrospinal fluid contribute to determining the presence of acute, subacute, or chronic brain injuries and predicting their outcomes.
Career Highlights: Ronald L. Hayes has had a distinguished career, contributing significantly to both research and practical applications in neuroscience. He has worked with notable organizations, including the University of Florida Research Foundation, and Banyan Biomarkers, Inc., playing a key role in advancing diagnostic capabilities in the field.
Collaborations: Throughout his career, Ronald has collaborated with other esteemed professionals in his field, including Monika Oli and Kevin Ka-Wang Wang. These partnerships have fostered innovation and enhanced the development of cutting-edge diagnostic tools.
Conclusion: Ronald L. Hayes's dedication to advancing neurological diagnostics is exemplified through his patents and collaborative efforts. His innovative contributions will undoubtedly continue to play a crucial role in the early detection and treatment of brain injuries and neurological conditions, reflecting the profound impact of his work on medical science.